SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/20 Genethera Inc 10-K 12/31/19 42:2.1M Highland Services/FA |
Document/Exhibit Description Pages Size 1: 10-K Genethera, Inc. 10-K HTML 453K 2: EX-31.1 Certifications of Principal Executive Officer HTML 21K Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 3: EX-31.2 Certifications of Principal Financial and HTML 21K Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 4: EX-32.1 Certification of Principal Executive Officer HTML 16K Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 5: EX-32.2 Certification of Principal Financial and HTML 16K Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 39: R1 Document and Entity Information HTML 56K 23: R2 Consolidated Balance Sheets HTML 87K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 36K 27: R4 Consolidated Statements of Operations HTML 53K 38: R5 Consolidated Statements of Stockholders' Equity HTML 60K (Deficit) 22: R6 Consolidated Statements of Cash Flows HTML 83K 17: R7 Organization and nature of operations and summary HTML 51K of significant accounting policies 26: R8 Going Concern HTML 19K 40: R9 Accrued expenses HTML 20K 37: R10 Related party transactions HTML 22K 33: R11 Other Income and Accrued Liabilities HTML 22K 13: R12 Convertible notes payable HTML 23K 25: R13 Shareholders' equity HTML 40K 36: R14 Commitments and Contingencies HTML 39K 32: R15 Income Taxes HTML 31K 12: R16 Subsequent events HTML 19K 24: R17 Organization and nature of operations and summary HTML 101K of significant accounting policies (Policies) 35: R18 Accrued expenses (Tables) HTML 20K 34: R19 Other Income and Accrued Liabilities (Tables) HTML 21K 15: R20 Income Taxes (Tables) HTML 26K 21: R21 Organization and nature of operations and summary HTML 19K of significant accounting policies (Details Narrative) 42: R22 Going Concern (Details Narrative) HTML 19K 29: R23 Accrued expenses (Details) HTML 25K 14: R24 Related party transactions (Details Narrative) HTML 32K 20: R25 Other Income and Accrued Liabilities (Details) HTML 16K 41: R26 Shareholders' equity (Details Narrative) HTML 36K 28: R27 Income Taxes (Details) HTML 22K 16: R28 Income Taxes (Details 2) HTML 24K 30: XML IDEA XML File -- Filing Summary XML 67K 19: EXCEL IDEA Workbook of Financial Reports XLSX 44K 6: EX-101.INS XBRL Instance -- gnth-20191231 XML 409K 8: EX-101.CAL XBRL Calculations -- gnth-20191231_cal XML 84K 9: EX-101.DEF XBRL Definitions -- gnth-20191231_def XML 167K 10: EX-101.LAB XBRL Labels -- gnth-20191231_lab XML 391K 11: EX-101.PRE XBRL Presentations -- gnth-20191231_pre XML 300K 7: EX-101.SCH XBRL Schema -- gnth-20191231 XSD 69K 31: ZIP XBRL Zipped Folder -- 0001199835-20-000136-xbrl Zip 60K
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Tannya L. Irizarry, the Interim Chief Financial Officer of GeneThera, Inc. (the “Company”), DOES HEREBY CERTIFY that:
1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
IN WITNESS WHEREOF, the undersigned has executed this statement this 10th day of June, 2020.
/s/ Tannya L. Irizarry | |
Tannya
L. Irizarry Interim Chief Financial Officer (Principal Financial and Accounting Officer) |
A signed original of this written statement required by Section 906 has been provided to GeneThera, Inc. and will be retained by GeneThera, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
C:
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/10/20 | |||
For Period end: | 12/31/19 | NT 10-K | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/25/20 SEC UPLOAD¶ 10/27/20 2:39K Genethera Inc. 9/18/20 SEC UPLOAD¶ 10/27/20 2:43K Genethera Inc. |